Brian Miller,
Oncology Fellow
Brian Miller received his M.D. Ph.D. from Washington University in St. Louis, where he studied the functions of autophagy genes in lymphocyte survival and osteoclast function with Dr. Skip Virgin. He completed his residency in Internal Medicine at Duke University Hospital and is currently a clinical fellow in hematology/oncology at the Dana-Farber Cancer Institute. He is working to understand the mechanisms by which anti-PD-1 therapy augments the anti-tumor immune response under the mentorship of Dr. Nicholas Haining, an expert in the field of systems biology and immunology, and Dr. Arlene H. Sharpe, an expert in T cell costimulation and inhibition. His goal is to define the immunologic changes required for anti-PD-1 function to predict which patients will respond, to understand mechanisms of resistance, and to design rational immunotherapy combinations.
|
|
|
